Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 2Recruiting 1

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other 2Head & Neck 2

Conditions

Leukemia, Myeloid, Acute 24Breast Neoplasms 14Neoplasms 12Myelodysplastic Syndromes 12Prostatic Neoplasms 10Multiple Myeloma 8Lung Neoplasms 7Stomach Neoplasms 6Sarcoma 6Ovarian Neoplasms 5Leukemia, Myelomonocytic, Chronic 5Recurrence 4Neoplasm Metastasis 4Lymphoma, Non-Hodgkin 4Head and Neck Neoplasms 4Colorectal Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Advanced Solid Tumor 4Uterine Cervical Neoplasms 3Squamous Cell Carcinoma of Head and Neck 3Solid Tumor 3Pain 3Mucositis 3Lymphoma, T-Cell, Peripheral 3Cholangiocarcinoma 3Carcinoma, Transitional Cell 3Carcinoma, Hepatocellular 3Stomatitis 2Small Cell Lung Carcinoma 2Skin Neoplasms 2

Interventions

Fibroblast Growth Factor 7 9avasopasem manganese 4Low-Level Light Therapy 4Cisplatin 4Mouthwashes 3Control Groups 3Water 2Standard of Care 2Sodium Chloride 2Sodium Bicarbonate 2Radiotherapy, Intensity-Modulated 2Radiotherapy 2Propolis 2Laser Therapy 2Injections 2FGF20 protein, human 2Drug Therapy 2Chlorhexidine 2Benzydamine 2Ascorbic Acid 2whole grape extract 1sargramostim 1samital 1peppermint oil 1oxycodone-acetaminophen 1meclocycline 1golotimod 1dusquetide 1calcium phosphate 1brilacidin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Stomatitis × Injections × Clear all
NCT03515538 2024-11-04

PREVLAR

EpicentRx, Inc.

Phase 2 Completed
53 enrolled 15 charts
Head & NeckOther

Head and Neck Neoplasms, Mouth Neoplasms, Stomatitis, Mucositis

NCT02324335 2019-01-16

Brilacidin

Innovation Pharmaceuticals, Inc.

Phase 2 Completed
61 enrolled 12 charts
Head & NeckOther

Head and Neck Neoplasms, Stomatitis, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡